PARP inhibitors in ovarian and other cancers
Plummer, R.; Plummer, R.
Clinical Advances in Hematology and Oncology H&o 13(5): 285-287
2015
ISSN/ISBN: 1543-0790 PMID: 26352770 Document Number: 680747
Document emailed within 1 workday
Related Documents
Tripathy, D. 2011: PARP inhibitors: the story is still unfolding Oncology 25(11): 1028; 1030Patel, A.; Kaufmann, S.H. 2010: Development of PARP inhibitors: an unfinished story Oncology 24(1): 66; 68
Del Rivero, J.; Kohn, E.C. 2017: PARP Inhibitors: the Cornerstone of DNA Repair-Targeted Therapies Oncology 31(4): 265-273
He, Y.-J.; Liu, R.-H.; Ning, C.-Q.; Yu, N.-F. 2013: Research progresses of the PARP inhibitors for the treatment of cancer Yao Xue Xue Bao 48(5): 655-660
Griffin, R.J.; Pemberton, L.C.; Rhodes, D.; Bleasdale, C.; Bowman, K.; Calvert, A.H.; Curtin, N.J.; Durkacz, B.W.; Newell, D.R.; Porteous, J.K. 1995: Novel potent inhibitors of the DNA repair enzyme poly(ADP-ribose)polymerase (PARP) Anti-Cancer Drug Design 10(6): 507-514
Garber, J. 2017: Judy Garber on PARP Inhibitors for Triple-Negative Breast Cancer Oncology 31(11): 814
Palma, J.P.; Rodriguez, L.E.; Bontcheva-Diaz, V.D.; Bouska, J.J.; Bukofzer, G.; Colon-Lopez, M.; Guan, R.; Jarvis, K.; Johnson, E.F.; Klinghofer, V.; Liu, X.; Olson, A.; Saltarelli, M.J.; Shi, Y.; Stavropoulos, J.A.; Zhu, G.-D.; Penning, T.D.; Luo, Y.; Giranda, V.L.; Rosenberg, S.H.; Frost, D.J.; Donawho, C.K. 2008: The PARP inhibitor, ABT-888 potentiates temozolomide: correlation with drug levels and reduction in PARP activity in vivo Anticancer Research 28(5a): 2625-2635
Maassen, V.; Debus-Thiede, G. 1994: Ovarian cancers and simultaneous primary cancers of the upper female genital tract Zentralblatt für Gynakologie 116(9): 527-530
Zhang, J.; Kan, Y.; Tian, Y.; Wang, Z.; Zhang, J. 2013: Effects of poly (ADP-ribosyl) polymerase (PARP) inhibitor on cisplatin resistance and proliferation of the ovarian cancer C13* cells Indian Journal of Medical Research 137(3): 527-532
Pogrebniak, A.; Schemainda, I.; Pelka-Fleischer, R.; Nüssler, V.; Hasmann, M. 2003: Poly ADP-ribose polymerase (PARP) inhibitors transiently protect leukemia cells from alkylating agent induced cell death by three different effects European Journal of Medical Research 8(10): 438-450
Kumari, S.R.; Mendoza-Alvarez, H.; Alvarez-Gonzalez, R. 1998: Functional interactions of p53 with poly(ADP-ribose) polymerase (PARP) during apoptosis following DNA damage: covalent poly(ADP-ribosyl)ation of p53 by exogenous PARP and noncovalent binding of p53 to the M(r) 85,000 proteolytic fragment Cancer Research 58(22): 5075-5078
Wang, P.H.; Chang, C. 2004: Androgens and ovarian cancers European Journal of Gynaecological Oncology 25(2): 157-163
Giuntoli, R.L.; Rodriguez, G.C.; Whitaker, R.S.; Dodge, R.; Voynow, J.A. 1998: Mucin gene expression in ovarian cancers Cancer Research 58(23): 5546-5550
Bian, M.L.; Lang, J.H. 1994: Advances in the genetic research on ovarian cancers Zhonghua Fu Chan Ke Za Zhi 29(3): 181-183
Chudecka-Głaz, A.; Rzepka-Górska, I.; Kośmider, M. 2002: Age at diagnosis and other prognosticators in epithelial ovarian cancers International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 78(1): 65-67
Piver, M.S.; Lurain, J. 1979: Childhood ovarian cancers. new advances in treatment New York State Journal of Medicine 79(8): 1196-1199
Posawetz, W.; Jakse, R.; Petru, E.; Pickel, H.; Heydarfadai, M. 1990: Scalenus biopsy in diagnosis of ovarian and uterine cancers Hno 38(10): 367-369
Picaud, A.; Walter, P.; Minko Mi Etoua, D.; Faye, A.; N'Sounda, C.; Nlome Nze, A.R.; Lunven, B. 1992: Stage IIi and IV epithelial ovarian cancers. Therapeutic problems Revue Francaise de Gynecologie et d'Obstetrique 87(1): 1-6
Lorimier, G.; Reigner, B.; Rive, C.; Cronier, P.; Talha, A.; Guntz, M. 1988: Ovarian metastases of digestive cancers. Diagnostic and therapeutic management Journal de Chirurgie 125(12): 699-703
Rothenberg, M.L.; Young, R.C. 1988: Changing concepts in the management of epithelial ovarian and cervical cancers Medical Journal of Australia 148(7): 354-363